Clotting catastrophe due to the COVID mRNA-DNA gene injections (vaccines): "Analysis of Thromboembolic & Thrombocytopenic Events After AZD1222, Pfizer, & Moderna COVID-19 Vaccines in 3 Nordic nations"

Jacob Dag Berild et al.: "there was an increased rate of hospital contacts because of coagulation disorders & cerebrovascular disease, especially for thrombocytopenia & cerebral venous thrombosis"

Now you would have thought that this very important study would be in the media 24/7 and there would be CNN talking head doctors discussing the catastrophic clotting and cardiovascular and cerebrovascular findings. But no, not in Canada, not in the US, in fact nowhere. Except places like here. Studies like these are swept under the rug, hidden from you!

But here it is and I spoke on this prior but wanted to remind you what was found and all at CDC, NIH, FDA, Biden administration, Francis Collins, Fauci, Bourla, Bancel, Walensky, Njoo, Tam at Health Canada etc., they all know the findings. This is but one study, there are many showing you the dangers of these COVID gene injections. I am saying that in time, we want these people properly investigated and in proper courts and if shown that they were reckless and caused deaths, we take all their money and imprison them. Deep prison time. Hang ’em high by taking their money, all of it.

SOURCE:

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2793348

In the 28-day period post vaccination for all three gene injections, there was an elevated rate of coronary artery disease following Moderna vaccination (RR, 1.13 [95% CI, 1.02-1.25])... There was an observed increased rate of coagulation disorders following all 3 vaccines (AZD1222: RR, 2.01 [95% CI, 1.75-2.31]; Pfizer: RR, 1.12 [95% CI, 1.07-1.19]; and Moderna: RR, 1.26 [95% CI, 1.07-1.47]).

There was also an observed increased rate of cerebrovascular disease following all 3 vaccines (AZD1222: RR, 1.32 [95% CI, 1.16-1.52]; Pfizer: RR, 1.09 [95% CI, 1.05-1.13]; and Moderna: RR, 1.21 [95% CI, 1.09-1.35]).

For individual diseases within the main outcomes, 2 notably high rates were observed: 12.04 (95% CI, 5.37-26.99) for cerebral venous thrombosis and 4.29 (95% CI, 2.96-6.20) for thrombocytopenia, corresponding to 1.6 (95% CI, 0.6-2.6) and 4.9 (95% CI, 2.9-6.9) excess events per 100 000 doses, respectively, following AZD1222 vaccination.’